Table 5.

Patients With Response or SD During EC145 Therapy

Patient No.	Dose Cohort (mg)	Mode of Administration	Tumor Type	Sex	Age (years)	Race	Best Response	Duration of PR or SD (days)
003	1.2	Bolus	Head and neck	M	61	White	SD	95
004	2.5	Bolus	Ovarian	F	64	White	SD	172
005	2.5	Bolus	Lung	M	67	Black	SD	42
010	2.5	Bolus	Ovarian	F	65	White	PR	111
011	2.5	Bolus	Nerve sheath	M	33	White	SD	82
015	2.5	Bolus	Head and neck	M	57	Black	SD	117
021	2.5	Infusion	Head and neck	F	43	White	SD	211

Abbreviations: PR, partial response; SD, stable disease.